The future prespective and development in pharmaco-geneticندوة

by Dr م.د. زينب غالب عليوي (فرع علم الادوية)

Monday 19 Feb 2024, 09:00 → 11:00 Asia/Baghdad

قاعة الكندي (College of Medicine)

Inter-individual variability in drug response is common and likely to become an increasing problem globally. Reasons for this inter-individual variability include genetic factors, an area of study called Pharmacogenetics (also called pharmacogenomics) which can be defined as the study of how the genes affect the way body responds to certain medicines. With genotyping technologies now widely available and decreasing in cost, implementing pharmacogenetics into clinical practice is widely regarded as one of the initial steps in mainstreaming genomic medicine and is currently a focus in many countries worldwide. Pharmacogenetic testing provides information about genes to help the health care provider choose the medicine and dosage that are the "best fit" for the individual. The tests use a sample of saliva (spit), blood, or cells swabbed from the cheek.  

PGx Z pdf2.pdf